SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc and Danish pharmaceutical company ALK-Abelló A/S have signed an agreement that will enable a substantial increase in Zydis ® oral ...
Catalent Pharma Solutions says the demand for products at its plant in Swindon, U.K., is "changing," and so it is reducing head count there by nearly four dozen employees. The 158,000-square-foot ...
NEW YORK — Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health ...
ALK-Abello will back the new production line for tablet-based allergy products. Catalent Pharma Solutions and ALK-Abello are collaborating to increase Zydis® oral dissolving tablet production capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results